Opko Health (OPK) Non Operating Investment Income (2010 - 2013)
Opko Health's (OPK) quarterly Non Operating Investment Income came in at -$2.4 million in Q2 2013, down 399.16% YoY from $792558.1 in Q2 2012, and up 39.05% on a QoQ basis from -$3.9 million in Q1 2013.
Opko Health (OPK) Non Operating Investment Income (2010 - 2013) Analysis & Trends
Opko Health (OPK) has 4 years of Non Operating Investment Income data on file, last reported at -$2.4 million in Q2 2013.
- Quarterly Non Operating Investment Income fell 399.16% year-over-year to -$2.4 million in Q2 2013, while the trailing twelve-month figure through Jun 2013 was -$7.3 million (down 327.73% YoY) and the FY2012 annual result came in at -$2.1 million, down 29.77% from the prior year.
- Non Operating Investment Income rose to -$2.4 million in Q2 2013, from -$3.9 million in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of -$31000.0 in Q4 2010 to a low of -$3.9 million in Q1 2013.
- A 4-year average of -$799769.2 and a median of -$451000.0 in 2011 frame the typical range for Non Operating Investment Income.
- Annual changes were most pronounced in 2011 — Non Operating Investment Income plunged 1235.48% — and 2012, when it decreased 5.32%.
- Tracing OPK's Non Operating Investment Income over 4 years: stood at -$31000.0 in 2010, then sank by 1235.48% to -$414000.0 in 2011, then sank by 44.44% to -$598000.0 in 2012, then tumbled by 296.49% to -$2.4 million in 2013.
- The last three Non Operating Investment Income figures came in at -$2.4 million (Q2 2013), -$3.9 million (Q1 2013), and -$598000.0 (Q4 2012), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | Opko Health | 1.13 Bn | 824.59 Mn | 80.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | -2.37 Mn |
| Jun 30, 2013 | -2.37 Mn |
| Mar 31, 2013 | -3.89 Mn |
| Mar 31, 2013 | -3.89 Mn |
| Dec 31, 2012 | -598,000.00 |
| Dec 31, 2012 | -598,000.00 |
| Sep 30, 2012 | -468,000.00 |
| Sep 30, 2012 | -468,000.00 |
| Jun 30, 2012 | -475,000.00 |
| Jun 30, 2012 | -475,000.00 |
| Mar 31, 2012 | -523,000.00 |
| Mar 31, 2012 | -523,000.00 |
| Dec 31, 2011 | -414,000.00 |
| Dec 31, 2011 | -414,000.00 |
| Sep 30, 2011 | -301,000.00 |
| Sep 30, 2011 | -301,000.00 |
| Jun 30, 2011 | -451,000.00 |
| Jun 30, 2011 | -451,000.00 |
| Mar 31, 2011 | -423,000.00 |
| Mar 31, 2011 | -423,000.00 |